Transcription Factor Therapeutics: Long-shot or Lodestone

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|6|691-701

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.6, 2005-03, pp. : 691-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patenting transcription factors for drug discovery and therapeutics

By Manning A.M.   Gonzales R.   Bennett B.L.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic modulation of transcription factor activity

By Emery J.G.   Ohlstein E.H.   Jaye M.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 5, 2001-05 ,pp. : 233-240

Elsevier

Access to resources Recommend Favorite

Growth Factor Signaling: Implications for Disease & Therapeutics

By Buch Shilpa  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 65-68

Springer Publishing Company

Access to resources Recommend Favorite

Genital herpes vaccine no longer a long shot?

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Preface: Transcription Factor as Molecular Targets: Is Transcription Factor Decoy a Novel Drug ? [Hot topic: Transcription Factor as Molecular Targets (Guest Editor: Ryuichi Morishita)]

By  

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite